Ocrelizumab Pregnancy Registry

10/09/2019
21/07/2025
EU PAS number:
EUPAS31342
Study
Finalised
Documents
Study protocol
Initial protocol
English (2.1 MB - PDF) View document
Updated protocol
English (1.18 MB - PDF) View document
Study results
Study results
English (400.98 KB - PDF) View document
Study report
Other information